NASDAQ · Financial Statements
Trevi Therapeutics, Inc. (TRVI) Financial Statements
$13.07
NASDAQ: TRVI
Market Cap $1.85B
Overview Financials Dividend Trevi Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-43.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-32.0M $-30.0M $-34.0M $-52.0M $-49.0M Net Profit $-34.0M $-29.0M $-29.0M $-48.0M $-43.0M EPS $-1.49 $-0.45 $-0.29 $-0.47 $-0.29 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $38.0M $123.0M $89.0M $111.0M $193.0M Total Liabilities $21.0M $16.0M $7.0M $11.0M $10.0M Cash $37.0M $13.0M $32.0M $34.0M $19.0M Borrowings $15.0M $9.0M $1.0M $1.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-29.0M $-28.0M $-32.0M $-38.0M $-42.0M Investing Cash Flow $0 $-108.0M $59.0M $-22.0M $-94.0M Financing Cash Flow $0 $12.0M $0 $0 $1.0M Net Cash Flow $-8.0M $-24.0M $20.0M $2.0M $-15.0M Free Cash Flow $-29.0M $-28.0M $-32.0M $-38.0M $-42.0M
Valuation & Return Ratios
Metric Value PEG Ratio -2.27 EV / EBITDA -39.63 FCF Yield -1.90% Quick Ratio 37.28 Interest Coverage 0.00 Return 1Y 148.00% Return 3Y 638.72% Return 5Y 776.77%
Screens featuring this stock